Elsevier

Disease-a-Month

Volume 40, Issue 6, June 1994, Pages 258-299
Disease-a-Month

Crystals and arthritis

https://doi.org/10.1016/0011-5029(94)90021-3Get rights and content

Abstract

Monosodium urate, calcium pyrophosphate dihydrate, and basic calcium phosphate (carbonate-substituted hydroxyapatite and octacalcium phosphate) crystal aggregates are associated with gout, pseudogout, and cartilage degeneration (osteoarthritis, Milwaukee Shoulder/Knee Syndrome), respectively. Hyperuricemia is a frequent but nonspecific and inconstant feature of gout just as an elevated synovial fluid inorganic pyrophosphate level is an inconstant feature of pseudogout. Monosodium urate, calcium pyrophosphate dihydrate, or basic calcium phosphate crystals can cause acute inflammation associated with phagocytosis by neutrophilic leukocytes. Each induces neutral protease synthesis and secretion and arachidonic acid metabolism by synoviocytes and macrophages in a dose-dependent fashion, postulated to produce the damage to bone, cartilage, and other joint tissues that is perceived clinically as tophaceous destruction or degenerative joint disease. Crystals containing calcium are potent mitogens. All three types of crystals are more common in older persons and will attract additional attention as the mean age of our population increases. Gout is perhaps the most treatable disease in medicine, although mistakes in diagnosis and in choice of appropriate therapy are very common. Acute pseudogout and acute calcific periarthritis are readily treated medically, but the chronic effects of crystals containing calcium are not. New approaches using drugs derived from scientific study of the biologic effects of these crystals may become useful therapeutically.

References (117)

  • DJ McCarty et al.

    Crystal populations in human synovial fluid

  • NN Kohn et al.

    The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudogout syndrome”. II. Identification of crystals

    Ann Intern Med

    (1962)
  • EH Brown et al.

    Preparation and characterization of some calcium pyrophosphates

    J Agricult Food Chem

    (1963)
  • F Mandl

    Zur pathologie und therapie der zwischenknorpelerkrankungen des kniegelenks

    Arch Klin Chir

    (1927)
  • K Werwath

    Abnorme kalkblagerungen inner halb des kniegelenks, ein betrag zur frage der primen meniskopathie

    Fortschr Boentgenstr Nuclear Med

    (1928)
  • D Zitnan et al.

    Articular chondrocalcinosis

    Ann Rheumat Dis

    (1963)
  • EH Bennett

    Abnormal deposits in joints

    Dublin J Med Sci

    (1903)
  • McCarty DJ. Phagocytosis of urate crystals in gouty synovial fluid. Am J Med Sci...
  • JF Seegmiller et al.

    The inflammatory reaction to sodium urate

    JAMA

    (1962)
  • DJ McCarty et al.

    Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response

    J Exp Med

    (1966)
  • P Phelps et al.

    Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes

    J Exp Med

    (1966)
  • JM Brill et al.

    Studies on the nature of gouty tophi, an abridged translation with comments by Freudweiler M and His W, 1899

    Ann Intern Med

    (1964)
  • JM Brill et al.

    Translation of experimental investigations into the origin of gouty tophi by Freudweiler M

    Arthritis Rheum

    (1965)
  • DJ McCarty

    A historical note: Leeuwenhoek's description of crystals from a gouty tophus

    Arthritis Rheum

    (1970)
  • F Kozin et al.

    Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals: relationship to the pathogenesis of crystal-induced inflammation

    Arthritis Rheum

    (1976)
  • F Kozin et al.

    Protein binding to monosodium urate monohydrate, calcium pyrophosphate and silicon dioxide crystals I. Physical characteristics

    J Lab Clin Med

    (1977)
  • F Kozin et al.

    Protein binding to monosodium urate crystals and its effect on platelet degranulation

    Adv Exp Med

    (1976)
  • MH Ginsberg et al.

    The release of platelet constituents by monosodium urate crystals

    J Clin Invest

    (1977)
  • F Kozin et al.

    Molecular orientation of immunoglobulin G absorbed to microcrystalline monosodium urate monohydrate

    J Lab Clin Med

    (1980)
  • R Terkeltaub et al.

    Plasma protein binding by monosodium urate crystals: analysis by two-dimensional gel electrophoresis

    Arthritis Rheum

    (1983)
  • PC Giclas et al.

    Immunoglobulin G independent activation of the classical complement pathway by sodium urate crystals

    J Clin Invest

    (1979)
  • IJ Russell et al.

    Effects of IgG and c-reactive protein on complement depletion by monosodium urate crystals

    J Rheumatol

    (1983)
  • WR Wallingford et al.

    Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate

    J Exp Med

    (1971)
  • H Cheung et al.

    Kinetics of collagenase and neutral protease release by neutrophils exposed to microcrystalline sodium urate

    Connect Tissue Res

    (1983)
  • S Hoffstein et al.

    Mechanisms of lysosomal enzyme release from leukocytes IV interaction of monosodium urate crystals with dogfish and human leukocytes

    Arthritis Rheum

    (1975)
  • P Phelps et al.

    Crystal induced arthritis

    Postgrad Med

    (1969)
  • P Phelps

    Polymorphonuclear leukocyte motility in vitro III. Possible release of chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes

    Arthritis Rheum

    (1969)
  • P Phelps et al.

    Demonstration of chemotactic factor in human gout

    J Rheumatol

    (1981)
  • I Spilberg et al.

    Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor

    J Clin Invest

    (1979)
  • P Phelps

    Polymorphonuclear leukocytes motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals

    Arthritis Rheum

    (1970)
  • I Krakoff
  • C Bowles

    Colchicine prevents recurrent pseudogout

    Arthritis Rheum

    (1986)
  • A Alvarellos et al.

    Colchicine prophylaxis in pseudogout

    J Rheumalol

    (1986)
  • I Spilberg et al.

    Colchicine and pseudogout

    Arthritis Rheum

    (1980)
  • WM Roberts et al.

    Colchicine in acute gout

    JAMA

    (1987)
  • RA Terkeltaub

    Pathogenesis and treatment of crystal-induced inflammation

  • DJ McCarty

    Synovial Fluid

  • DJ McCarty

    Gout without hyperuricemia

    JAMA

    (1994)
  • DJ McCarty et al.

    Serum and urinary uric acid

  • JN Loeb

    The influence of temperature on the solubility of monosodium urate

    Arthritis Rheum

    (1972)
  • Cited by (61)

    • Dexamethasone causes calcium deposition and degeneration in human anterior cruciate ligament cells through endoplasmic reticulum stress

      2020, Biochemical Pharmacology
      Citation Excerpt :

      Another study found that Dex treatment causes tendinous cells to form non-tendinous tissues (such as fat, chondral, and bone), making the tendon vulnerable to rupture [11]. Studies have shown that calcium deposition may be the latest event of ACL degeneration and that ACL calcification can even occur without cartilage calcification in some cases [36,46]. In this study, we found time- and concentration-independent increase in calcium deposition in human ACL cells treated with Dex, suggesting that the long-term effect of Dex causes an increase in calcium deposition in ACL cells.

    • Calcium Pyrophosphate Dihydrate Deposition Disease

      2015, Mineral Scales and Deposits: Scientific and Technological Approaches
    • Imaging in the crystal arthropathies

      2014, Rheumatic Disease Clinics of North America
      Citation Excerpt :

      These findings highlight the unique nature of the osteopathology of gout, which contrasts with that of immune-mediated arthropathies such as RA. CPPD crystal deposition disease is a common form of crystalline arthropathy characterized clinically by a variety of patterns including the most common asymptomatic state (radiographic chondrocalcinosis, Fig. 7), acute monoarthritis (pseudogout), and a symmetric polyarticular destructive arthropathy that mimics RA.56 A formal diagnosis of CPPD crystal deposition disease requires synovial fluid analysis and the finding of typical rhomboidal crystals with specific birefringence characteristics.

    • Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response

      2007, International Immunopharmacology
      Citation Excerpt :

      Polymethylmethacrylate (PMMA) particles generated by the breakdown of implanted prosthetics, such as the articulating surfaces of hip or knee replacements, migrate into various tissues and lead to activation of the host's inflammatory and immune responses [16]. In crystal deposition diseases such as arthritis and gout, it is the crystals of calcium pyrophosphate dihydrate (CPPD) or monosodium urate monohydrate (MSUM) that instigate painful acute inflammation after phagocytosis [15,17]. Basic calcium phosphate crystals (BCP, various admixtures of hydroxyapatite (HAP), octacalcium phosphate and tricalcium phosphate) are the particulates associated with the inflammation of osteoarthritis [18].

    View all citing articles on Scopus
    View full text